In this section, we focus on vaccines based on mannan carrier-antigen complex/conjugations, including mannan-mucin 1 (MUC1) fusion protein conjugation for tumor therapy, mannan-DNA vaccine and mannan-allergy vaccines. This evidence concerns the gene MUC1 and neoplasm.